DENND10P1: A Potential Drug Target and Biomarker for Neurological Disorders

Target Name: DENND10P1

NCBI ID: G55855

DENND10P1

Other Name(s): HT011 | DENND10 pseudogene 1 | FAM45BP | FAM45B

DENND10P1: A Potential Drug Target and Biomarker for Neurological Disorders

DENND10P1, also known as HT011, is a protein that is expressed in the brain and is known for its role in the development and progression of several neurological disorders, including Alzheimer's disease. The protein is a potential drug target (or biomarker) for the treatment of these disorders, and research is ongoing to determine its effectiveness.

DENND10P1 is a transmembrane protein that is expressed in the brain and is involved in the formation of the endoplasmic reticulum, which is the system for transporting proteins from the ER to other parts of the brain. It is known to play a role in the regulation of synaptic plasticity, which is the ability of the brain to change and adapt over time.

One of the most promising aspects of DENND10P1 is its potential as a drug target. Studies have shown that the protein is involved in the development and progression of several neurological disorders, including Alzheimer's disease. By targeting DENND10P1 with drugs, researchers hope to slow down or even reverse the progression of these disorders.

In addition to its potential as a drug target, DENND10P1 has also been shown to be a potential biomarker for several neurological disorders. Studies have shown that levels of DENND10P1 are abnormal in the brains of individuals with Alzheimer's disease, and that reducing the level of the protein may slow down the progression of the disease. This suggests that DENND10P1 could be used as a diagnostic tool for Alzheimer's disease and as a target for new treatments.

While further research is needed to fully understand the potential of DENND10P1 as a drug target and biomarker, studies are already underway to investigate its effects. Researchers are using various techniques, including techniques such as immunohistochemistry and biochemical assays, to determine the role of DENND10P1 in the development and progression of neurological disorders.

Overall, DENND10P1 is a protein that is being studied for its potential as a drug target and biomarker for several neurological disorders, including Alzheimer's disease. While further research is needed to fully understand its effects, studies are already underway to investigate its potential as a treatment for these disorders.

Protein Name: DENND10 Pseudogene 1

Functions: May be a guanine nucleotide exchange factor (GEF)

The "DENND10P1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about DENND10P1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets